COLUMBIA, MD--(Marketwire - September 08, 2011) - Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, announced today that Michael H. Tardugno, Celsion’s President and Chief Executive Officer, will be presenting at the Rodman & Renshaw 13th Annual Healthcare Conference on Monday, September 12th at 2:50 P.M. Eastern Time, at the Waldorf=Astoria in New York City.
A live audio-only webcast of the presentation will be available on Celsion’s website at http://www.celsion.com/events.cfm. The webcast will be archived on the same site for replay following the conference.
About Celsion Corporation
Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems. Celsion has research, license, or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, and the North Shore Long Island Jewish Health System.
For more information on Celsion, visit our website: http://www.celsion.com.
Investor Contact
David Pitts
Argot Partners
212-600-1902
Email Contact
